Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Coagulopathy associated with vitamin E ingestion.

Corrigan JJ Jr, Marcus FI.

JAMA. 1974 Dec 2;230(9):1300-1. No abstract available.

PMID:
4479598
2.

Hypervitaminosis E and coagulation.

[No authors listed]

Nutr Rev. 1975 Sep;33(9):269-70. Review. No abstract available.

PMID:
1099483
3.

Warfarin therapy. 1.

Deykin D.

N Engl J Med. 1970 Sep 24;283(13):691-4. Review. No abstract available.

PMID:
4916914
4.

Megavitamin E supplementation and vitamin K-dependent carboxylation.

[No authors listed]

Nutr Rev. 1983 Sep;41(9):268-70. Review. No abstract available.

PMID:
6358960
5.

Toxin-induced coagulopathy.

Chai P, Babu K.

Emerg Med Clin North Am. 2014 Feb;32(1):53-78. doi: 10.1016/j.emc.2013.10.001. Review.

PMID:
24275169
6.

How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage.

Goodnough LT, Shander A.

Blood. 2011 Jun 9;117(23):6091-9. doi: 10.1182/blood-2010-11-316075. Epub 2011 Mar 16. Review.

7.

Reversal of warfarin-induced coagulopathy: review of treatment options.

Hall AB, Carson BC.

J Emerg Nurs. 2012 Jan;38(1):98-101. doi: 10.1016/j.jen.2010.12.015. Epub 2011 Apr 6. Review. No abstract available.

PMID:
21474171
8.

The liver and blood coagulation: physiology and pathology.

Roberts HR, Cederbaum AI.

Gastroenterology. 1972 Aug;63(2):297-320. Review. No abstract available.

PMID:
4558715
9.

Control of clotting factor biosynthesis by vitamin K.

Suttie JW.

Fed Proc. 1969 Sep-Oct;28(5):1696-701. Review. No abstract available.

PMID:
4897771
10.

Coagulopathies in hepatic disease.

Kang Y.

Liver Transpl. 2000 Jul;6(4 Suppl 1):S72-5. Review. No abstract available.

PMID:
10915195
11.

The challenge of regulating anticoagulant drugs: focus on warfarin.

Mann KG.

Am Heart J. 2005 Jan;149(1 Suppl):S36-42. Review. No abstract available.

PMID:
15644792
12.

Treatment of warfarin-associated coagulopathy with vitamin K.

Patriquin C, Crowther M.

Expert Rev Hematol. 2011 Dec;4(6):657-65; quiz 666-7. doi: 10.1586/ehm.11.59. Review.

PMID:
22077529
13.

Hazards of anticoagulant treatment: other drugs, other diseases.

O'Reilly RA.

Thromb Diath Haemorrh Suppl. 1973;56:211-7. Review. No abstract available.

PMID:
4142116
14.

The pharmacodynamics of the oral anticoagulant drugs.

O'Reilly RA.

Prog Hemost Thromb. 1974;2(0):175-213. Review. No abstract available.

PMID:
4137288
15.

Diagnosis of hemorrhagic disorders.

Nemerson Y.

Med Clin North Am. 1973 Mar;57(2):531-41. Review. No abstract available.

PMID:
4570937
16.

Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.

Dentali F, Ageno W, Crowther M.

J Thromb Haemost. 2006 Sep;4(9):1853-63. Review.

17.

[Drug-induced coagulation disorders].

Higashihara M, Aoki T.

Nihon Rinsho. 2007 Oct 28;65 Suppl 8:487-92. Review. Japanese. No abstract available.

PMID:
18074588
18.

Neonatal coagulation defects.

Turner TL.

Clin Endocrinol Metab. 1976 Mar;5(1):89-106. Review. No abstract available.

PMID:
776463
19.

[Acquired coagulation disorders in children].

Bulucea D.

Rev Pediatr Obstet Ginecol Pediatr. 1985 Oct-Dec;34(4):315-25. Review. Romanian. No abstract available.

PMID:
3938049
20.

Reversal of drug-induced anticoagulation: old solutions and new problems.

Dzik WS.

Transfusion. 2012 May;52 Suppl 1:45S-55S. doi: 10.1111/j.1537-2995.2012.03690.x. Review.

PMID:
22578371

Supplemental Content

Support Center